Exposure to diet, drugs and early life adversity during sensitive windows of life 1,2 can lead to lasting changes in gene expression that contribute to the display of physiological and behavioural phenotypes. Such environmental programming is likely to increase the susceptibility to metabolic, cardiovascular and mental diseases 3, 4 .
. Note: Considering that RNA is less stable than DNA in the GTC-Buffer, we recommend processing RNA first. The homogenate used for DNA purification can be kept at room temperature (RT) during that time.
1. Homogenize punches using a pipette and vortexer in 400 μl of guanidinium thiocyanate (GTC) buffer (4.5 M guanidinium thiocyanate, 2% Nlauroylsarcosine, 50 mM EDTA pH 8.25 mM Tris-HCl pH 7.5, 0.1 M beta-mercaptoethanol, 0.2% antifoam A) at RT, passing several times through a hypodermic syringe (29G) (Figure 2 ). 2. Split lysate into equal parts; both RNA and DNA may be extracted at the same time or separately, depending on particular experimental needs. 3. For RNA purification add 1/10 volume of NaOAc, 1 volume AquaPhenol (Appligene) (pH 4) and 1/2 volume of chloroform:isoamyl (24:1) to lysate. Vortex vigorously after each step and incubate on ice for 10 min, centrifuge (20 min at 10,000 g at 4 °C); add an equal volume of 70% EtOH to aequous phase. 4 . Transfer mixture to an RNA spin column (e.g. Nucleospin RNA II from Macherey-Nagel) and perform on-column DNase-digestion and washing steps (follow manufacturer's protocol); elute RNA in 25 μl H 2 O. 5. For DNA purification an optimized protocol of the Qiagen DNeasy Blood and Tissue Kit is used. Equilibrate lysate with equal volumes of Buffer AL and 100% EtOH, load on a Spin Column centrifuge (1 min at 10,000 g at RT) and discard flow-through. 6. Add 500 μl Buffer AW1 including 5 μl RNAse (1 mg/ml) to column and incubate 10 min at RT. Spin (1 min at 10,000 g, RT) and discard flowthrough. 7. Wash column with 500 μl Buffer AW2, discard flow-through and spin-dry empty column (1 min at 15,000 g). 8 . Add prewarmed (70 °C) Buffer AE and incubate columns for 10 min at 70 °C. Elute by centrifugation (1 min, 10,000 g), re-apply flow-through and repeat centrifugation step.
Use a spectrophotometer to determine DNA and RNA concentrations. A typical PVN punch yields ~600 ng DNA and ~400 ng RNA. For gene expression analysis by quantitative PCR (qPCR), we typically use ~100 ng of RNA in the reverse transcription reaction.
Bisulfite Conversion
Sodium Bisulfite is used to convert non-methylated cytosines to uracils. In contrast, methylated cytosines are protected from conversion. Therefore, all cytosines that are detected in the final sequencing of the bisulfite PCR-amplicon represent methylated cytosines.
Bisulfite conversion causes substantial DNA degradation which can be a limiting factor in PCR analysis. Optimized reaction conditions that maximize cytosine conversion, reduce DNA fragmentation and maintain single-stranded DNA even at lower temperatures can be achieved using Qiagen's EpiTect Bisulfite Kit. In our hands ~200 ng of DNA purified from micropunches provide a sufficient amount of starting material for the bisulfite reaction.
To prevent differences in the efficiency of the conversion reaction, the amount of template DNA should be kept constant among all samples processed during an experiment. In addition, sequence reads should be scrutinized for conversion efficiency by examining the rate of nonconverted non-CpGs. This rate should exceed 98%. Lower values indicate incomplete or inefficient bisulfite conversion and the underlying sequences should be excluded from the analysis. Analyze 7 μl of PCR product by agarose gel electrophoresis to verify size of the amplicon and purify remaining PCR reaction for subsequent ligation using a commercially available PCR clean-up kit (e.g. Macherey-Nagel Nucleospin Extract). In case additional undesired PCR products are obtained, gel purification is recommended.
Bisulfite PCR

Bisulfite Sequencing
High-resolution DNA methylation profiles deduced from single clone readings can detect small changes in DNA methylation and identify regulatory regions that are responsive to treatment (environmental programming). The bisulfite sequencing process comprises three consecutive working steps. Firstly, PCR products obtained by prior bisulfite PCR are ligated into a vector and transformed into bacteria. Secondly, colony PCR from single clones is employed to determine the correct size of the insert. Thirdly, positive colony PCRs are cleaned up and subjected to Big-Dye sequencing reaction. Following a clean-up step, products are electrophoresed on a capillary sequencer.
Ligation and Transformation
Note: We routinely use the pGEM-T vector cloning kit (Promega). In our experience, the cloning efficiency depends critically on the insert to be ligated. Different vectors should be tested in case low numbers of recombinant clones are repeatedly obtained. 
Transformation of ligation products in electrocompetent bacteria
1. Precool electroporation cuvettes (1 mm width) on ice and thaw aliquot of electrocompetent DH5α bacteria on ice. 2. Add 45 μl DH5α bacteria to 10 μl cleaned up ligation product (see above) and transfer to cuvette. 3. Transform bacteria at 1.5 kV, 200 Ω, 15 μF and add 1 ml of prewarmed SOB medium directly after pulse delivery. 4. Recover bacteria for 1 h at 37 °C, spread 100 μl of suspension on LB/ampicillin plates coated with IPTG/X-Gal. 5. Incubate plates overnight at 37 °C.
Colony PCR
Note: Colony PCR from single clones is conducted to ensure that inserts are of predicted size. Delayed color development from the blue/white screening, undesired recombination events during ligation, incorporation of oligomeric primer pairs or truncated PCR products may otherwise lead to faulty sequencing results. We routinely use T7 and SP6 primers to amplify cloned inserts; this approach results in additional vector sequences of approximately 150 bp. T7 primer is used in the sequencing reaction in a later step. 
Representative Results
To gain insight into the influence of ELS on the Avp expression and methylation status, C57BL/6N mice were processed according to the workflow described above. Briefly, a group of C57BL/6N mice was subjected to ELS while the control group was left undisturbed. The PVN and the supraoptic nucleus (SON) were punched and DNA and RNA were isolated simultaneously from the single punches. RNA was reverse transcribed and the levels of Avp transcripts were measured by qPCR analysis and normalized to the expression of Hprt and Gapdh housekeeping genes. DNA was bisulfite treated, amplified with primers specific to the Avp enhancer (Figure 4a ) and the PCR products were cloned and sequenced. At least 20 recombinant clones from each mouse/PCR were analyzed to determine methylation frequencies for the CpGs contained in the PCR amplicon (Figure 4b) . Compared to controls, ELS induced a significant hypomethylation at CpG10, CpG12, CpG13 and Cpg14 of the Avp enhancer (p < 0.05, n = 6-8 animals) suggesting epigenetic marking of this regulatory region through early-life experiences. In contrast to the PVN, methylation of the Avp enhancer was unaffected by ELS in the SON illustrating tissue specificity of epigenetic marking (Figure 4c) . Analysis of the DNA methylation status at CpG10 and Avp gene expression in control animals (n = 6) evidenced a negative correlation pointing to a role of DNA methylation in the fine-tuning of AVP gene expression (Figure 4d) . 
Discussion
Epigenetic programming is increasingly recognized as an important mechanism underlying health and disease. Here we present a refined method for the simultaneous isolation of DNA and RNA from micropunches and the subsequent steps to obtain DNA methylation profiles through bisulfite sequencing. The optimized workflow allows convenient analysis of epigenetic programming in the brain in response to environmental stimuli. Moreover, this approach facilitates the investigation of the functional relationship between DNA methylation and gene expression as both are analyzed from the same sample. Finally, animal numbers needed for the experiment can be significantly reduced.
Certain precautions and guidelines should be followed while performing the presented workflow. Considering the extraordinary complexity and heterogeneity of the brain and since methylation and expression pattern may vary in a cell-and tissue specific manner it is of utmost importance that micropunching is performed in a standardized manner. As a case in point, epigenetic programming of Avp is detected in the paravaventriuclar, but not in the supraoptic nucleus (Figure 4b-d) , two Avp expressing regions of the hypothalamus 4 . In this respect, availability of DNA and RNA from the same tissue punch is advantageous as RNA expression of certain tissue specific marker genes can be used in some cases to certify that the correct area was punched. Although micropunching can reduce cellular heterogeneity, it has to be remembered that this approach does not lead to the isolation of single cell types or populations. Additional purification steps might be considered to address this topic.
For bisulfite sequencing optimal primer design for PCR amplification following bisulfite treatment is essential. PCR products exceeding 400 bp in length can be problematic due to the degradation of DNA by the bisulfite treatment. It should be also noted that nested PCR can give biased results if only a few intact templates contribute to the amplification process. Primer pairs that are specific for the modified amplicon should Copyright © 2012 Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License July 2012 | 65 | e3938 | Page 6 of 6 be designed; their sequences should not contain CpG dinucleotides in order to avoid methylation-biased amplification. In addition, primers should contain non-CpG cytosines to prevent amplification of unmodified or incompletely converted DNA. Amplification of some templates may benefit from conducting Hot-start PCR. In any case, suitability of primer pairs should be verified in pilot experiments so as to prevent spoilage of valuable experimental specimens.
Bisulfite sequencing represents a standard method for site-specific methylation analysis as it is able to reliably and precisely detect the methylation of single CpG residues in an allele-specific manner 8 . Direct sequencing of the PCR product is not advised as mixed methylation of a CpG residue will appear as a C/T double peak in the electropherogram, which can prevent quantification of methylation at the site concerned. For this reason an intermediate cloning step is conducted and several clones are sequenced (~20-30) to determine the extent of methylation. Pyrosequencing represents an alternative method to quantify DNA methylation. It also utilizes bisulfite conversion and bisulfite PCR but instead of cloning and sequencing the amplicon is subjected to a direct pyrosequencing reaction where the methylation status of a CpG residue is read as a C/T single nucleotide polymorphism that can be easily quantified. Both methods detect similar levels of methylation 9 but since the cloningstep can be omitted pyrosequencing is more time-efficient. However, depending on the template only 40-100 nucleotides can be sequenced at once so that several rounds of pyrosequencing with different sequencing primer are necessary. This is a critical limitation, given that higher amounts of DNA (about 1 μg per reaction) are required, which foreseeable exceed the amounts available from tiny brain tissue punches. Thus initial scanning of regions in the range of several kilobases by pyrosequencing appears less suited as single clone reading. Nevertheless, following on identification of a small region of interest pyrosequencing should be considered.
Collectively, the protocol described above provides an accurate, efficient and streamlined approach for the rapid and cost-effective analysis of brain micropunches for epigenetic changes. Multiple specimens can be processed in a single run and the methods are suitable when running samples from intermediate-sized experiments.
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